Drug Shortage Report for MINT-OLANZAPINE ODT
Report ID | 108298 |
Drug Identification Number | 02436973 |
Brand name | MINT-OLANZAPINE ODT |
Common or Proper name | Olanzapine |
Company Name | MINT PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | OLANZAPINE |
Strength(s) | 10MG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | ORAL |
Packaging size | 30 count Blisters |
ATC code | N05AH |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2020-03-09 |
Estimated end date | |
Actual end date | 2021-01-15 |
Shortage status | Resolved |
Updated date | 2021-01-16 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-03-09 | English | Compare |
v2 | 2020-03-09 | French | Compare |
v3 | 2020-03-10 | English | Compare |
v4 | 2021-01-15 | English | Compare |
v5 | 2021-01-15 | French | Compare |
v6 | 2021-01-16 | English | Compare |
Showing 1 to 6 of 6